Bridgeway Capital Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.2K Hold
115,000
﹤0.01% 1099
2025
Q1
$125K Sell
115,000
-100,000
-47% -$109K ﹤0.01% 1001
2024
Q4
$215K Buy
215,000
+22,200
+12% +$22.2K ﹤0.01% 987
2024
Q3
$318K Buy
192,800
+90,000
+88% +$149K 0.01% 966
2024
Q2
$114K Hold
102,800
﹤0.01% 1151
2024
Q1
$136K Sell
102,800
-10,000
-9% -$13.2K ﹤0.01% 1173
2023
Q4
$169K Sell
112,800
-35,000
-24% -$52.5K ﹤0.01% 1169
2023
Q3
$217K Buy
147,800
+50,000
+51% +$73.5K 0.01% 1084
2023
Q2
$245K Sell
97,800
-53,000
-35% -$133K 0.01% 1088
2023
Q1
$225K Buy
150,800
+50,000
+50% +$74.5K 0.01% 1084
2022
Q4
$141K Buy
100,800
+10,000
+11% +$14K ﹤0.01% 1162
2022
Q3
$287K Buy
90,800
+53,000
+140% +$168K 0.01% 1056
2022
Q2
$131K Sell
37,800
-60,000
-61% -$208K ﹤0.01% 1176
2022
Q1
$1.11M Hold
97,800
0.02% 757
2021
Q4
$936K Sell
97,800
-23,000
-19% -$220K 0.02% 802
2021
Q3
$1.07M Buy
+120,800
New +$1.07M 0.02% 800
2018
Q3
Sell
-4,665
Closed -$1.28M 1447
2018
Q2
$1.28M Buy
4,665
+1,250
+37% +$342K 0.01% 778
2018
Q1
$929K Buy
3,415
+1,195
+54% +$325K 0.01% 878
2017
Q4
$528K Sell
2,220
-2,155
-49% -$513K 0.01% 1078
2017
Q3
$884K Buy
4,375
+875
+25% +$177K 0.01% 885
2017
Q2
$406K Buy
3,500
+1,250
+56% +$145K ﹤0.01% 1144
2017
Q1
$360K Hold
2,250
﹤0.01% 1159
2016
Q4
$392K Hold
2,250
0.01% 1165
2016
Q3
$551K Buy
+2,250
New +$551K 0.01% 1050